Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that plays a crucial role in the management of type 2 diabetes mellitus. It functions by mimicking the action of the incretin hormone GLP-1, which enhances insulin secretion in response to meals, thereby aiding in the regulation of blood glucose levels.

In addition to its glucose-lowering effects, semaglutide has been shown to promote weight loss, making it a valuable option for patients with obesity-related metabolic disorders. Its mechanism involves delaying gastric emptying and reducing appetite, contributing to its efficacy in weight management.

Semaglutide is typically administered via subcutaneous injection, allowing for sustained release and prolonged action in the body. This pharmacokinetic profile supports its use in once-weekly dosing regimens, improving patient adherence and convenience.

Clinical studies have demonstrated semaglutide's effectiveness in reducing HbA1c levels and achieving significant weight reduction, with a favorable safety profile. Common side effects include gastrointestinal disturbances, such as nausea and diarrhea, which are generally transient and diminish over time.

As a compounding pharmacy, Bayview Pharmacy offers customized formulations of semaglutide to meet specific patient needs, ensuring optimal therapeutic outcomes. Healthcare providers may consider semaglutide for patients who require additional glycemic control or those who benefit from its weight loss properties.